BUDGET IMPACT ANALYSIS FOR OLICERIDINE IN THE MANAGEMENT OF MODERATE TO SEVERE ACUTE POSTOPERATIVE PAIN

被引：0
|
作者：
Simpson, K. [1 ]
Wase, L. [2 ]
Fossler, M. J. [2 ]
Demitrack, M. A. [2 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Trevena Inc, Chesterbrook, PA USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG6
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [31] BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL IN THE MANAGEMENT OF PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS IN GREECE
    Tzanetakos, C.
    Maniadakis, N.
    Kourlaba, G.
    Tzioufas, A.
    Goules, A.
    Theodoratou, T.
    Christou, P.
    VALUE IN HEALTH, 2014, 17 (07) : 375 - 375
  • [32] Predictors for moderate to severe acute postoperative pain after total hip and knee replacement
    Liu, Spencer S.
    Buvanendran, Asokumar
    Rathmell, James P.
    Sawhney, Mona
    Bae, James J.
    Moric, Mario
    Perros, Stephen
    Pope, Ashley J.
    Poultsides, Lazaros
    Della Valle, Craig J.
    Shin, Naomi S.
    McCartney, Colin J. L.
    Ma, Yan
    Shah, Mahendrakumar
    Wood, Monica J.
    Manion, Smith C.
    Sculco, Thomas P.
    INTERNATIONAL ORTHOPAEDICS, 2012, 36 (11) : 2261 - 2267
  • [33] Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients
    Porela-Tiihonen, Susanna
    Kokki, Merja
    Kokki, Hannu
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (02) : 101 - 111
  • [34] MANAGEMENT OF ACUTE AND POSTOPERATIVE PAIN
    TORDA, TA
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 1983, 21 (04) : 27 - 46
  • [35] Acute postoperative pain management
    Small, C.
    Laycock, H.
    BRITISH JOURNAL OF SURGERY, 2020, 107 (02) : E70 - E80
  • [36] BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA
    Al Jedai, A.
    AL-Mudaiheem, H.
    Aldail, M.
    Fatani, M.
    Binamer, Y.
    Sharma, Y.
    Mohamed, O.
    Awad, N.
    Al-Amaa, T.
    VALUE IN HEALTH, 2020, 23 : S17 - S17
  • [37] BUDGET IMPACT ANALYSIS OF USTEKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN THAILAND
    Tangwongsiri, D.
    Leartsakulpanitch, J.
    VALUE IN HEALTH, 2012, 15 (07) : A679 - A679
  • [38] BUDGET IMPACT ANALYSIS OF TRALOKINUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UK
    Chalmers, K.
    Sawyer, L.
    Sohrt, A.
    Robinson, S.
    Ryttig, L.
    Rinciog, C.
    VALUE IN HEALTH, 2022, 25 (12) : S124 - S124
  • [39] BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN GREECE
    Gourzoulidis, G.
    Rigopoulos, D.
    Kountouris, V
    Christou, P.
    Tzanetakos, C.
    VALUE IN HEALTH, 2019, 22 : S422 - S422
  • [40] BIOLOGIC TREATMENTS FOR MODERATE TO SEVERE NAIVE PSORIATIC PATIENTS: A BUDGET IMPACT ANALYSIS IN ITALY
    Povero, M.
    Pradelli, L.
    VALUE IN HEALTH, 2015, 18 (07) : A663 - A664
12345